Cantitate/Preț
Produs

Hydroxychloroquine and Chloroquine Retinopathy

Autor David J. Browning
en Limba Engleză Hardback – 10 mai 2014
Malpractice settlements are large for undetected hydroxychloroquine and chloroquine toxicity which, if untreated, can lead to permanent loss of central vision. Knowledge of the ocular toxicity of these drugs has increased during the past fifty years as their use has expanded. Hydroxychloroquine and Chloroquine Retinopathy is the first single-source book on the subject and is essential for the practicing ophthalmologists, rheumatologists, dermatologists, and internists who prescribe these drugs. It covers clinical topics such as signs and symptoms of toxicity, toxicity screening, ancillary testing, to whom and why the drugs are prescribed and dosing considerations. Additionally, the book addresses practice management considerations, including coding, reimbursement and equipment costs, and the medico-legal responsibilities of the rheumatologist and of the ophthalmologist. Guidelines for the management of hydroxychloroquine and chloroquine vary around the world and differences between the guidelines of the United Kingdom, the United States, and other countries are identified. The book concludes with a collection of case examples illustrating common clinical scenarios and their management. This book is a “must-have” resource for physicians who use these drugs.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 56005 lei  39-44 zile
  Springer – 3 sep 2016 56005 lei  39-44 zile
Hardback (1) 14998 lei  24 ore
  Springer – 10 mai 2014 14998 lei  24 ore

Preț: 14998 lei

Preț vechi: 49993 lei
-70%

Puncte Express: 225

Preț estimativ în valută:
2871 3113$ 2447£

Carte în stoc

Livrare din stoc 24 mai

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781493905966
ISBN-10: 1493905961
Pagini: 291
Ilustrații: XV, 291 p. 113 illus. in color.
Dimensiuni: 178 x 254 x 20 mm
Greutate: 0.91 kg
Ediția:2014
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States

Public țintă

Professional/practitioner

Cuprins

1. Preclinical Foundations: Relevant Anatomy and Physiology.- 2. Pharmacology of Chloroquine and Hydroxychloroquine.- 3. Toxicology of Hydroxychloroquine and Chloroquine and the Pathology of the Retinopathy They Cause.- 4. Definitions of Hydroxychloroquine and Chloroquine Retinopathy.- 5. Epidemiology of Hydroxychloroquine and Chloroquine Retinopathy.- 6. Natural History of Hydroxychloroquine and Chloroquine Retinopathy.- 7. Risk Factors for Hydroxychloroquine and Chloroquine Retinopathy.- 8. Ancillary Testing in Screening for Hydroxychloroquine and Chloroquine Retinopathy.- 9. Screening for Hydroxychloroquine and Chloroquine Retinopathy.- 10. Clinical Examples in Managing Patients Taking 4-Aminoquinolines.


Notă biografică

David J. Browning, MD, PhD is an ophthalmologist with a PhD in pharmacology and is on the editorial board of the American Journal of Ophthalmology. He has published two books with Springer, Diabetic Retinopathy and Retinal Vein Occlusions.


Textul de pe ultima copertă

Malpractice settlements are large for undetected hydroxychloroquine and chloroquine toxicity which, if untreated, can lead to permanent loss of central vision. Knowledge of the ocular toxicity of these drugs has increased during the past fifty years as their use has expanded. Hydroxychloroquine and Chloroquine Retinopathy is the first single-source book on the subject and is essential for the practicing ophthalmologists, rheumatologists, dermatologists, and internists who prescribe these drugs. It covers clinical topics such as signs and symptoms of toxicity, toxicity screening, ancillary testing, to whom and why the drugs are prescribed and dosing considerations. Additionally, the book addresses practice management considerations, including coding, reimbursement and equipment costs, and the medico-legal responsibilities of the rheumatologist and of the ophthalmologist. Guidelines for the management of hydroxychloroquine and chloroquine vary around the world and differences between the guidelines of the United Kingdom, the United States, and other countries are identified. The book concludes with a collection of case examples illustrating common clinical scenarios and their management. This book is a “must-have” resource for physicians who use these drugs.


Caracteristici

First dedicated text on clinical management of ocular toxicity of hydroxychloroquine and chloroquine
Written for the practicing ophthalmologist, rheumatologist, dermatologist, and internist
Different treatment guidelines from around the world presented
Covers fundamentals, including pharmacology, toxicology, toxicity screening and evolution of the drugs' use
Lays out important financial and medico-legal considerations, including coding and reimbursement and the clinician’s legal responsibility

Descriere

Malpractice settlements are large for undetected hydroxychloroquine and chloroquine toxicity which, if untreated, can lead to permanent loss of central vision. Knowledge of the ocular toxicity of these drugs has increased during the past fifty years as their use has expanded. Hydroxychloroquine and Chloroquine Retinopathy is the first single-source book on the subject and is essential for the practicing ophthalmologists, rheumatologists, dermatologists, and internists who prescribe these drugs. It covers clinical topics such as signs and symptoms of toxicity, toxicity screening, ancillary testing, to whom and why the drugs are prescribed and dosing considerations. Additionally, the book addresses practice management considerations, including coding, reimbursement and equipment costs, and the medico-legal responsibilities of the rheumatologist and of the ophthalmologist. Guidelines for the management of hydroxychloroquine and chloroquine vary around the world and differences between the guidelines of the United Kingdom, the United States, and other countries are identified. The book concludes with a collection of case examples illustrating common clinical scenarios and their management. This book is a “must-have” resource for physicians who use these drugs.